Innoviva Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
United States of America US
Employees
159
IPO date
Oct 5, 2004

Innoviva is a healthcare royalty company. Its main business is owning rights to receive payments on medicines developed and sold by other companies, especially inhaled treatments for lung diseases. Instead of running a big drug sales force, Innoviva sits further up the value chain and collects income when partner products sell well.

The company makes money mainly through royalty payments and, in some cases, through milestones or other contractual payments tied to partnered drug programs. Its main economic customers are really the pharmaceutical partners that market these medicines, along with the patients and doctors who use the products they sell. Innoviva’s role is different from a typical drug maker because it usually does not manufacture or market the medicines itself; it owns a stream of cash flows from intellectual property and collaboration agreements.

This model gives Innoviva a business built around healthcare assets rather than a broad product portfolio. The key things that drive its results are the sales of the partnered therapies and the strength of the underlying patent and licensing agreements. For investors, that makes Innoviva easier to think of as a royalty and licensing business than as a traditional pharmaceutical company.

Innoviva Inc Investor Relations

Address
1350 Old Bayshore Highway, Suite 400
Burlingame, California
United States of America

Business Segments

Royalty portfolio

Innoviva owns royalty rights on respiratory medicines sold by GSK, including inhaled treatments for asthma and COPD. It does not make the drugs itself; it collects income tied to sales of those products.

Customers and revenue model

Healthcare investments

Innoviva also holds and manages investments in healthcare companies and related assets, including stakes in drug development businesses.

Customers and revenue model

Management

Mr. Stephen Basso M.B.A.

Chief Financial Officer

Biography unavailable

Ms. Patricia M. Drake

Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.

Biography unavailable

1 / 2